Ads
related to: abbvie upadacitinib- Is RINVOQ Right For You?
RINVOQ® Could Be Right For You.
See RINVOQ® Clinical Trial Results.
- Watch Video
What Is RINVOQ®?
Watch A Video To Learn More.
- RINVOQ® Complete
Get Access To Prescription Savings
And Insurance Coverage Info.
- Save With Savings Program
Information About Your Co-Pay
And Affordability, If Eligible.
- FDA-Approved Rx Treatment
Explore RINVOQ® Treatment.
RINVOQ® May Be Right For You.
- Important Safety Info
Read The Full Safety
& Prescribing Info For RINVOQ®.
- Is RINVOQ Right For You?
Search results
AbbVie's (ABBV) Rinvoq Meets Key Goal in Phase II Vitiligo Study
Zacks via Yahoo Finance· 7 months agoAbbVie ABBV announced positive results from its mid-stage study evaluating Rinvoq (upadacitinib) in...
AbbVie (ABBV) Outperforms Industry This Year So Far: Here's Why
Zacks via Yahoo Finance· 2 years agoAbbVie (ABBV) has several new drugs with the potential to drive revenues once Humira loses U.S....
Here's How Much a $1000 Investment in AbbVie Made 10 Years Ago Would Be Worth Today
Zacks via Yahoo Finance· 5 months agoHow much a stock's price changes over time is important for most investors, since price performance...
AbbVie (ABBV) Provides Clinical Updates on Inflammatory Drugs
Zacks via Yahoo Finance· 1 year agoAbbVie ABBV announced multiple clinical updates pertaining to clinical studies evaluating its...
AbbVie (ABBV) to Boost Immunology Pipeline With New Acquisition
Zacks via Yahoo Finance· 2 years agoAbbVie Inc. ABBV recently announced that it has acquired UK-based private biotech, DJS Antibodies...
Can AbbVie's (ABBV) New Drugs Make up for Lost Humira Sales?
Zacks via Yahoo Finance· 2 years agoAbbVie's (ABBV) new drugs, Skyrizi and Rinvoq, are faring well, bolstered by approval in new...
AbbVie's (ABBV) Rinvoq Gets FDA Nod to Treat Crohn's Disease
Zacks via Yahoo Finance· 1 year agoAbbVie (ABBV) announces the seventh FDA approval of its JAK inhibitor, Rinvoq, for the treatment of...
Why AbbVie (ABBV) is a Top Value Stock for the Long-Term
Zacks via Yahoo Finance· 22 hours agoWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the...
AbbVie's (ABBV) Rinvoq Gets CHMP Nod for New Indication
Zacks via Yahoo Finance· 2 years agoAbbVie Inc. ABBV announced that the European Medicines Agency’s Committee for Medicinal Products for...
FDA Approves First Oral Treatment For Crohn's Disease, Making Seventh Approval For AbbVie's Rinvoq
Benzinga via Yahoo Finance· 1 year agoThe FDA approved AbbVie Inc's (NASDAQ: ABBV) Rinvoq (upadacitinib) for moderately to severely active...
Ads
related to: abbvie upadacitinib